Octagon Capital Advisors LP: BIOAGE LABS INC (BIOA): Quarterly 13F Position History
As of Q1 2026, Octagon Capital Advisors LP reported 1,748,000 shares of BIOAGE LABS INC (BIOA), worth $30.6M and representing 3.4% of its 13F equity book. Quarter-over-quarter share count change: + 150,000 (+9.4%) . The position first appeared in Q4 2025 and has been disclosed across 2 13F-HR filings in Pactolio's tracked window.
- 1,748,000Shares Held (Latest Filing)
- $30.6MReported Market Value (Latest Filing)
- 3.4%Portfolio Weight (% of 13F Equity Book)
- +150,000Quarter-over-Quarter Share Change
- +$9.4MQuarter-over-Quarter Value Change
- 1,748,000Peak Reported Shares (Historical)
Recent initiation: Octagon Capital Advisors LP first reported BIOA on the Q4 2025 filing — fewer than three quarters of history are available.
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 1,748,000 | +150,000 | +9.4% | $30.6M | 3.4% | $17.5 |
| Q4 2025 | 1,598,000 | — | — | $21.1M | 2.6% | $13.2 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Octagon Capital Advisors LP first disclose a BIOA position in 13F-HR filings?
Octagon Capital Advisors LP first reported BIOAGE LABS INC (BIOA) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 2 reported quarters within Pactolio's tracked window.
What was Octagon Capital Advisors LP's most recent quarter-over-quarter share-count change in BIOA?
Between Q4 2025 and Q1 2026, Octagon Capital Advisors LP added 150,000 shares of BIOA (+9.4%), bringing the total reported position to 1,748,000 shares at a market value of $30.6M.
Does the implied price-per-share represent Octagon Capital Advisors LP's cost basis in BIOA?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.